Status:
RECRUITING
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
Lead Sponsor:
XEOS Medical
Conditions:
Prostate Cancers
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This registry study aims to evaluate the effectiveness and clinical impact of specimen PET-CT imaging by analyzing the correlation between specimen PET-CT images, intraoperative interpretations, and h...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- All patients that were scheduled for resective surgery and for whom successful high-resolution PET-CT imaging was performed on their resected specimens using the AURA 10 PET-CT. Successful imaging means that the image contains at least a portion of the primary tumor, the radiotracer injection was correctly executed and there were no technical issues that lead to an uninterpretable PET-CT image. Or all patients that are scheduled for resective surgery and for whom high-resolution PET-CT imaging will be performed on their resected specimens using the AURA 10 PET-CT.
- Patients willing to provide informed consent for use of their relevant medical records. For retrospectively included patients with no further Long-Term Follow-Up (LTFU) data collection, a notification will be sent.
- Exclusion Criteria:
- Under the age of 18 years at the time of resective surgery.
- Women who are pregnant or breastfeeding.
Exclusion
Key Trial Info
Start Date :
November 19 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 15 2031
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT06970275
Start Date
November 19 2025
End Date
January 15 2031
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Maria Middelares
Ghent, Belgium